Your browser doesn't support javascript.
loading
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Pagani, Olivia; Gelber, Shari; Simoncini, Edda; Castiglione-Gertsch, Monica; Price, Karen N; Gelber, Richard D; Holmberg, Stig B; Crivellari, Diana; Collins, John; Lindtner, Jurij; Thürlimann, Beat; Fey, Martin F; Murray, Elizabeth; Forbes, John F; Coates, Alan S; Goldhirsch, Aron.
Affiliation
  • Pagani O; Oncology Institute of Southern Switzerland, Ospedale Italiano, Viganello, Lugano, Switzerland. olivia.pagani@ibcsg.org
Breast Cancer Res Treat ; 116(3): 491-500, 2009 Aug.
Article in En | MEDLINE | ID: mdl-18953651

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Estrogen / Endocrine System / Lymph Nodes / Neoplasms, Hormone-Dependent Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2009 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Estrogen / Endocrine System / Lymph Nodes / Neoplasms, Hormone-Dependent Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2009 Type: Article Affiliation country: Switzerland